Exporter

EN
FR
Mesna
Statut de médicament essentiel
Description générale
Testicular germ cell tumour  Ovarian germ cell tumour  Osteosarcoma  Rhabdomyosarcoma  Ewing sarcoma.
INN
Mesna
Codes ATC
V03AF01
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté en 2015 (TRS 994) pour Germ cell tumour of testis
Wikipédia
Mesna
DrugBank
Mesna (Coenzyme M)
Recommandations
Section
Supportive medicines
  • Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule; 100 mg per mL in 2 mL ampoule
  • Oral > Solid > tablet: 400 mg; 600 mg
  • Oral > Other: 600 mg
  • Oral > Solid > tablet: 400 mg
  • Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule
  • Oral > Solid: 400 mg; 600 mg
Indications
Osteosarcoma of bone and articular cartilage of other specified sites Rhabdomyosarcoma primary site Other specified malignant neoplasms of the ovary Germ cell tumour of testis Ewing sarcoma of bone and articular cartilage of unspecified sites Unspecified malignant neoplasms of ill-defined or unspecified sites Burkitt lymphoma including Burkitt leukaemia Malignant neoplasms of kidney, except renal pelvis